Senior insider sale
Chief Development Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$103.2K
13.03K shares
What this filing means
KAISER PETER plans to sell 13.03K shares of OCULAR THERAPEUTIX, INC valued at approximately $103.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/2/2026ACC: 0001950047-26-009999
Officer· Chief Development Officer
Since Feb 2026
13.03K
Shares to sell
$103.2K
Approx. market value
9.99K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Not Applicable
10/1/2026
9.99KTotal acquired9.99K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2026 | Restricted Stock Vesting Under a Registered Plan Not Applicable | 9.99K | — |
| Total | 9.99K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.04K
Market value
$32.7K
8/24/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.99K
Market value
$70.5K
10/2/2026
Total
Units
13.03K
Value
$103.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/24/2026 | 3.04K | $32.7K | — | Completed |
| Planned — Approximate Date | ||||
10/2/2026 | 9.99K | $70.5K | NASDAQ | Planned |
| Total | 13.03K | $103.2K | ||